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Background
HLA alleles are associated with differential outcomes of
infections/diseases. We hypothesize that epitopes that
interact with HLA alleles associated with resistance elicit
a protective immune response in the host, and could
therefore serve as good vaccine candidates. Among the
HLA alleles reported to be associated with resistance to
HIV infection/slow progression to AIDS, HLA-A*0201
occurs most frequently in the Indian population. We
undertook this study to identify HIV epitopes specific to
this HLA allele from HIV-1C.
Methods
1769 sequences of all proteins of Indian HIV-1C were
downloaded from the HIV sequence database and con-
sensus sequence for each protein was built. Epitopes
specific to HLA-A*0201, but not to any of the HLA
alleles known to be associated with susceptibility to
HIV/AIDS, were identified using ProPred1 and modeled
on to HLA-A*0201.
Results
Twenty six peptides specific to HLA-A*0201 were iden-
tified as better binders to the HLA molecule than a con-
trol peptide which is a known immunodominant HIV
epitope. Eleven of these have also been reported by
others as immunogenic. Ten of the 11 epitopes were
found to be conserved in Indie-C1, an infectious Indian
subtype C clone. Four epitopes were reported to elicit
CD4+ as well as CD8+ specific responses. Fifteen epi-
topes identified in this study are novel.
Conclusion
The short-listed epitopes could be tested for their
potential as vaccine candidates for the Indian HIV epi-
demic. This approach has been extended to identify epi-
topes specific to other HLA alleles associated with
resistance to HIV, and in vitro evaluation is being
undertaken.
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